T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$1.37B |
| 2 |
Intel
INTC
|
+$1.28B |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$1B |
| 4 |
Nike
NKE
|
+$859M |
| 5 |
Uber
UBER
|
+$825M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.67B |
| 2 |
Amazon
AMZN
|
+$2.15B |
| 3 |
NVIDIA
NVDA
|
+$1.64B |
| 4 |
Humana
HUM
|
+$1.57B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.09% |
| 2 | Healthcare | 15.81% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
LeMaitre Vascular
LMAT
$1.87B
| $281K | ﹤0.01% |
4,948
+517
| +12% | +$27.1K |
|
2402
Reynolds Consumer Products
REYN
$5.55B
| $281K | ﹤0.01% |
10,442
+1,378
| +15% | +$36K |
|
2403
Royal Bank of Canada
RY
$299B
| $281K | ﹤0.01% |
2,770
| – | – |
|
|
AMPS
2404
DELISTED
Altus Power
AMPS
| $281K | ﹤0.01% |
41,141
+7,581
| +23% | +$41K |
|
2405
ChargePoint
CHPT
$160M
| $280K | ﹤0.01% |
5,979
-2,538
| -30% | -$142K |
|
2406
Cytek Biosciences
CTKB
$636M
| $280K | ﹤0.01% |
30,678
+2,630
| +9% | +$16.6K |
|
2407
Community Health Systems
CYH
$419M
| $280K | ﹤0.01% |
89,175
+13,632
| +18% | +$36.8K |
|
2408
Sturm, Ruger & Co
RGR
$601M
| $280K | ﹤0.01% |
6,150
+209
| +4% | +$10K |
|
2409
Covenant Logistics
CVLG
$880M
| $279K | ﹤0.01% |
12,098
+298
| +3% | +$6.38K |
|
2410
MacroGenics
MGNX
$259M
| $278K | ﹤0.01% |
28,813
-4,198
| -13% | -$29K |
|
2411
Mastech Digital
MHH
$95.3M
| $278K | ﹤0.01% |
32,884
| – | – |
|
|
ONTF
2412
DELISTED
ON24
ONTF
| $278K | ﹤0.01% |
35,176
+415
| +1% | +$2.88K |
|
|
SNCY
2413
DELISTED
Sun Country Airlines
SNCY
| $278K | ﹤0.01% |
17,611
+2,932
| +20% | +$43.2K |
|
2414
LSB Industries
LXU
$711M
| $277K | ﹤0.01% |
29,744
+4,713
| +19% | +$43K |
|
2415
Vipshop
VIPS
$6.8B
| $277K | ﹤0.01% |
15,558
+68
| +0.4% | +$1.06K |
|
|
DSKE
2416
DELISTED
Daseke, Inc. Common Stock
DSKE
| $277K | ﹤0.01% |
34,076
+7,127
| +26% | +$34.5K |
|
|
VERV
2417
DELISTED
Verve Therapeutics
VERV
| $276K | ﹤0.01% |
19,766
+1,446
| +8% | +$17.9K |
|
2418
Vaalco Energy
EGY
$592M
| $275K | ﹤0.01% |
61,088
+1,723
| +3% | +$7.58K |
|
|
ETNB
2419
DELISTED
89bio
ETNB
| $271K | ﹤0.01% |
24,221
-358,024
| -94% | -$3.29M |
|
2420
Xeris Biopharma Holdings
XERS
$1.52B
| $271K | ﹤0.01% |
115,003
+2,180
| +2% | +$4.02K |
|
2421
Yext
YEXT
$613M
| $271K | ﹤0.01% |
45,887
-3,527
| -7% | -$21.7K |
|
2422
Beyond Meat
BYND
$210M
| $270K | ﹤0.01% |
30,314
-5,357
| -15% | -$42.1K |
|
2423
Hurco Companies Inc
HURC
$143M
| $270K | ﹤0.01% |
12,500
+400
| +3% | +$8.32K |
|
2424
MINISO
MNSO
$3.53B
| $268K | ﹤0.01% |
+13,100
| New | +$314K |
|
|
PLYM
2425
DELISTED
Plymouth Industrial REIT
PLYM
| $268K | ﹤0.01% |
11,116
+1,528
| +16% | +$33.2K |
|
Similar funds
T. Rowe Price Associates's Q4 2023 Portfolio in Review
As of Q4 2023, T. Rowe Price Associates held 2,974 positions worth $744B, up 9.1% from $682B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates's Q4 2023 filing shows 92 new, 1,834 increased, 805 reduced and 67 closed positions. Its largest new stake was Canadian Natural Resources: 6,473,658 shares worth $212M. The largest sale was Microsoft, an estimated $2.67B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2023 buy was Canadian Natural Resources: 6,473,658 shares worth $212M.
- T. Rowe Price Associates added most to Dollar General in Q4 2023, an estimated $1.37B increase.
- T. Rowe Price Associates's biggest Q4 2023 reduction was Microsoft, cutting an estimated $2.67B.
- T. Rowe Price Associates fully exited Activision Blizzard in Q4 2023, selling an estimated $293M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $744B portfolio in Q4 2023.
- T. Rowe Price Associates opened 92 new positions and closed 67 in Q4 2023.
- T. Rowe Price Associates's portfolio value rose 9.1% quarter-over-quarter to $744B.
Based on T. Rowe Price Associates's 13F filing for Q4 2023, filed 14 Feb 2024.